BUB1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.634800E-01
Normal-vs-Stage2
3.738400E-01
Normal-vs-Stage3
9.089800E-01
Normal-vs-Stage4
7.502600E-01
Stage1-vs-Stage2
7.778800E-01
Stage1-vs-Stage3
5.945600E-01
Stage1-vs-Stage4
7.863600E-01
Stage2-vs-Stage3
3.755800E-01
Stage2-vs-Stage4
5.605200E-01
Stage3-vs-Stage4
8.106800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.065600E-01
Normal-vs-AfricanAmerican
8.267000E-01
Normal-vs-Asian
5.237200E-01
Caucasian-vs-AfricanAmerican
3.937200E-01
Caucasian-vs-Asian
6.787400E-01
AfricanAmerican-vs-Asian
6.058800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.867400E-01
Normal-vs-Female
3.700000E-01
Male-vs-Female
1.706150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.977200E-01
Normal-vs-Age(41-60Yrs)
3.991200E-01
Normal-vs-Age(61-80Yrs)
4.488400E-01
Normal-vs-Age(81-100Yrs)
3.665400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.010400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.492200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.905600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.614000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.123800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.886800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.141800E-01
Normal-vs-Daily Drinker
4.962000E-01
Normal-vs-Weekly Drinker
4.409400E-01
Normal-vs-Occasional Drinker
4.002800E-01
Normal-vs-Social Drinker
3.835800E-01
Non Drinker-vs-Daily Drinker
9.073200E-01
Non Drinker-vs-Weekly Drinker
8.402200E-01
Non Drinker-vs-Occasional Drinker
9.881800E-01
Non Drinker-vs-Social Drinker
9.198800E-01
Daily Drinker-vs-Weekly Drinker
7.561000E-01
Daily Drinker-vs-Occasional Drinker
9.165600E-01
Daily Drinker-vs-Social Drinker
9.928800E-01
Weekly Drinker-vs-Occasional Drinker
8.181400E-01
Weekly Drinker-vs-Social Drinker
7.565600E-01
Occasional Drinker-vs-Social Drinker
9.196800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.636200E-01
Normal-vs-Grade 2
8.432800E-01
Normal-vs-Grade 3
9.224400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.968600E-04
Grade 1-vs-Grade 3
2.33919999998999E-05
Grade 1-vs-Grade 4
6.636200E-01
Grade 2-vs-Grade 3
1.437400E-01
Grade 2-vs-Grade 4
8.432800E-01
Grade 3-vs-Grade 4
9.224400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.678600E-01
Normal-vs-NonDiabetic
3.666200E-01
Diabetic-vs-NonDiabetic
1.345040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.037210E-01
Normal-vs-NoPancreatitis
4.558800E-01
Pancreatitis-vs-NoPancreatitis
2.422400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.982200E-01
Normal-vs-N1
3.933800E-01
N0-vs-N1
6.287200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.016300E-02
Normal-vs-TP53-NonMutant
5.151800E-01
TP53-Mutant-vs-TP53-NonMutant
3.08559999995239E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
